Publications & Works

Publication Network
Articles 23
All (23)
SCI-E, SSCI, AHCI (10)
SCI-E, SSCI, AHCI, ESCI (11)
ESCI (1)
Scopus (14)
TRDizin (10)
Other Publications (4)

1. Evaluation of 30-day mortality rate following intravenous systemic anticancer therapy: a retrospective analysis

ÇETİN T. E., SÜTCÜOĞLU O., AKDOĞAN O., SAVAŞ G., Günel N., ÜNER A., et al.
BMC Cancer , vol.25, no.1, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

2. The frequency of autoimmune disease in the first degree and other relatives of the breast cancer patients Meme kanserli hastaların birinci derece ve diğer yakınlarındaki otoimmün hastalık sıklığı

Atay A., GÖKER B., ÖZTÜRK M. A., TUFAN A., HAZNEDAROĞLU Ş., Babaoğlu H., et al.
Journal of Turkish Society For Rheumatology , vol.16, no.1, pp.32-37, 2024 (Scopus, TRDizin) Creative Commons License identifier identifier

3. Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy.

BİR YÜCEL K., Kilic A. C., SÜTCÜOĞLU O., YAZICI O., Kilic K., SAVAŞ G., et al.
Journal of chemotherapy (Florence, Italy) , vol.36, no.3, pp.249-257, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

4. The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma

ASLAN V., KARABÖRK KILIÇ A. C., ÖZET A., ÜNER A., GÜNEL N., YAZICI O., et al.
BMC Cancer , vol.23, no.1, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

5. Long-term outcomes of COVID-19 infection in patients with solid tumors

Ünsal O., YAZICI O., özkan ö. f., tahtaci g., Ozdemir N., Üner A., et al.
The European Research Journal , vol.9, no.5, pp.932-939, 2023 (TRDizin) Creative Commons License identifier

6. Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data

SÜTCÜOĞLU O., Doğan A., Yilmaz F., Şahin A. B., Şahin T. K., Esen S. A., et al.
Pancreas , vol.52, no.4, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

7. Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients

Yücel K. B., Özay Z. I., SÜTCÜOĞLU O., YAZICI O., ÜNER A., GÜNEL N., et al.
Supportive Care in Cancer , vol.31, no.2, 2023 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

8. LAG-3 expression in tumor microenvironment of triple-negative breast cancer

Tahtaci G., Gunel N., Sadioglu A., AKYÜREK N., Boz O., ÜNER A.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.53, no.1, pp.142-148, 2023 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

9. Association of Immunoscore, CD73 Expression and 53BP1 Expression with Neoadjuvant Chemoradiotherapy Efficacy in Patients with Locally Advanced Rectal Cancer

Sütcüoğlu O., İnan M. A., Üner A., Savaş G., Bora H., Özet A., et al.
Journal of oncological sciences , vol.9, no.1, pp.23-32, 2023 (Scopus, TRDizin) identifier identifier

10. Panreatiko Biliyer Tümörlerde Adjuvant Sistemik Tedavi

TAHTACI G., GÜNEL N.
türkiye klinikleri tıbbi onkoloji , 2021 (TRDizin)

11. Yaygın Evre Küçük Hücreli Akciğer Kanseri Sistemik Tedavisi

TAHTACI G., GÜNEL N.
Türkiye Klinikleri tıbbi onkoloji , 2021 (TRDizin) Sustainable Development

12. Prognostic Value of Mean Platelet Volume in Glioblastoma Multiforme

TAHTACI G., GÜNEL N., ÜNER A., TAHTACI M.
GAZI MEDICAL JOURNAL , vol.29, no.4, pp.336-339, 2018 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier

13. Long-term follow-up of a hip joint osteoblastoma after intralesional curettage and cement packing: a case report

Gunel U., Daglar B., GÜNEL N.
ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA , vol.47, no.3, pp.218-222, 2013 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

14. Serum neopterin levels in patients with breast cancer

Yildirim Y., GÜNEL N., Coskun U., PAŞAOĞLU H., Aslan S., Cetin A.
MEDICAL ONCOLOGY , vol.25, no.4, pp.403-407, 2008 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

15. Serum big endothelin-1 levels in female patients with breast cancer

Yildirim Y., GÜNEL N., Coskun U., Sancak B., BUKAN N., Aslan S., et al.
INTERNATIONAL IMMUNOPHARMACOLOGY , vol.8, no.8, pp.1119-1123, 2008 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

16. Temozolomide in newly diagnosed malignant gliomas: Administered concomitantly with radiotherapy, and thereafter as consolidation treatment

Yaman E., Buyukberber S., ÜNER A., Coskun U., AKMANSU M., Benekli M., et al.
ONKOLOGIE , vol.31, no.6, pp.309-313, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

17. A small cell lung carcinoma presenting with eaton-lambert myasthenic syndrome and acanthosis nigricans

GÜNEL N., YAMAÇ D., ÜNER A.
Turkish Journal of Cancer , vol.28, no.3, pp.130-133, 1998 (TRDizin)

18. Tropisetron ve ondansetronun cisplatine bağlı bulantı vekusmayı önleyici etkilerinin karşıklaştırılması.

ÜNER A., GÜNEL N., YAMAÇ D.
Türk Hematoloji Onkoloji Dergisi , vol.8, no.1, pp.23-26, 1998 (TRDizin)

19. The use of CA15-3 and estrogen receptor in breast cancer patients with bone metastases

KARAKAN T., GÜNEL N., AKÇALI Z., ÜNER A.
GAZI MEDICAL JOURNAL , vol.9, no.4, pp.149-153, 1998 (Scopus) Sustainable Development

20. Pyomyositis in a patient with lymphoma.

ÜNER A., ÇAKIR B., GÜNEL N., AKÇALI Z., YILMAZ M.
Türk Hematoloji Onkoloji Dergisi , vol.7, no.3, pp.169-171, 1997 (Peer-Reviewed Journal)

21. Evre II-IIIA meme kanserli premenopozal hastalarda adjuvant 6 kür CMF ve 3 kür CMF uygulamalarının karşılaştırmalı sonuçları.

DEMİRKAZIK A., İÇLİ F., SEZER M. T., KARAOĞUZ H., DİNÇOL D., GÜNEL N., et al.
Türk Hematoloji Onkoloji Dergisi , vol.3, no.3, pp.133-137, 1993 (Peer-Reviewed Journal) Sustainable Development

22. Kanser hastalarında infeksiyon ataklarının, infeksiyon düşündüren dönemlerin ve mikrobiyal kolonizasyonların değerlendirilmesi

WİLKE A., DİNÇOL D., DEMİRKAZIK A., GÜNEL N., KARAOĞUZ H., ÜNER A., et al.
Türk Hematoloji Onkoloji Dergisi , vol.2, no.3, pp.162-168, 1992 (Peer-Reviewed Journal) Sustainable Development

23. cisplatin based combination chemotherapy in metastatic testicular germ cell tumors

GÜNEL N., KARAOĞUZ H., İÇLİ F., DİNÇOL D., DEMİRKAZIK A., ÜNER A.
journal of ankara medical school , vol.14, no.2, pp.175-184, 1992 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences 19

1. The ability of the LACE index to predict 30-day readmissions in oncology patients

ULAŞ KAHYA B., YAZICI O., Sutcuoglu O., ÖZDEMİR N., Gunel N., ÜNER A., et al.
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 20 - 24 October 2023, (Summary Text) identifier

2. LOKAL İLERİ REKTUM KANSER TANILI HASTALARDA İMMÜNSKOR CD73 EKSPRESYONU VE 53BP1 EKSPRESYONUNUN NEOADJUVAN KEMORADYOTERAPİ ETKİNLİĞİ İLE İLİŞKİSİ

SÜTCÜOĞLU O., İNAN M. A., ÜNER A., SAVAŞ G., BORA H., ÖZET A., et al.
III. Ankara Hematoloji ve Onkoloji Günleri, Ankara, Turkey, 3 - 05 February 2023, (Summary Text)

3. SARKOPENİ VE OBEZİTENİN METASTATİK RCC HASTALARINDA İMMÜNOTERAPİ TEDAVİSİNİN ETKİNLİĞİNİ ÖNGÖRMEDEKİ ROLÜ,

Aslan V., Sütcüoğlu O., Ünsal O., Yazıcı O., Özdemir N., Üner A., et al.
8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021, (Summary Text)

4. TIBBİ ONKOLOJI SERVİS YATIŞ SÜRESİNİ ÖNGÖRMEDE HEMOGLOBİN, ALBÜMİN, LENFOSİT VE TROMBOSİT KOMBİNASYONUNUN DEĞERİ

Sütcüoğlu O., Ünsal O., Aslan V., Ulaş Kahya B., Tahtacı G., Özdemir N., et al.
8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 03 November 2021, (Summary Text)

5. ileri evre kolorektal kanserde RAS mutasyon durumu ve tümör lokalizasyonunun PET-BT 18F-FDG tutulumu ile ilişkisi

KURT İNCİ B., gürler F., YILMAZ M., TAHTACI G., YAZICI O., ÜNER A., et al.
2. ulusal immunoterapi ve onkoloji kongresi, Turkey, 31 October - 04 November 2018, (Full Text) Sustainable Development

6. Gemsitabine Bağlı Ciddi Periferik Odem

AKSAN S., BİLGETEKİN İ., KARACA M., ÜNER A., ÖZET A., GÜNEL N.
22.Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, (Summary Text)

7. Serum Hepatocyte growth factor and interleukin-6 levels in patients with primer, metastatic livir tumors and beniggn liver lesions

COŞKUN U., BUKAN N., ÇAYCI SİVRİ A. B., ÜNAL A., GÜNEL N., ÖZENİRLER MAYER S., et al.
15 th IFCC-FESCC European Congress ofClinical Chemistry and Laboratory Medicine, 1 - 05 June 2003

8. Expression of MUC1 and MUC2 mucins in gastric carcinomas their relationship with clinicopathologic parameters and prognosis

AKYÜREK N., AKYOL G., DURSUN A., DENİZ Y., GÜNEL N.
18TH EUROPEAN CONGRESS OF PATHOLOGY, Berlin, Germany, 8 - 13 September 2001, vol.198, pp.665-674, (Summary Text)

9. Soluble E-Selectin Levels in Patients with Colorectal Cancer

AKÇALI Z., ÜNER A., GÜNEL N., YAMAÇ D., YILDIRIM E.
Proceedings of American Society of Clinical Oncology, 20 - 23 May 2000, (Summary Text) Sustainable Development

10. Cisplatin Plus Vinorelbine as a Salvage Regimen in Refractory Breast Cancer.

GÜNEL N., AKÇALI Z., ÜNER A., YAMAÇ D., TÖRÜNER F. S., COŞKUN U.
Proceedings of American Society of Clinical Oncology, 15 - 18 May 1999, (Summary Text) Sustainable Development

11. Serum G-CSF levels in neutropenia devoloping after chemotherapy in patients with solid tumors.

GÜNEL N., ÜNER A., NAHİDE K., YAMAÇ D., AKÇALI Z.
21st Congress of the European Society for Medical Oncology, 1 - 05 November 1996, (Summary Text)

12. Serum G-CSF levels in neutropenia devoloping after chemotherapy in patients with solid tumors. Monduzzi Editore (International Proceedings Division),

GÜNEL N., ÜNER A., YAMAÇ D., AKÇALI Z.
10th Mediterranean Congress of Chemotherapy, 20 - 25 October 1996, (Summary Text)

13. 20 Yaş üzeri kadınların meme kanserine yönelik bilgi ve davranış biçimleri.

GÜNEL N., ÖZTAŞ D., ÜNER A., YAMAÇ D., ÇİFTLİK E. E.
V. Ulusal Halk Sağlığı Kongresi, Turkey, 12 - 16 October 1996, (Summary Text) Sustainable Development

14. Scintimammography with Tc-99m MDP in breast cancer.

KİTAPÇI M. T., ÜNER A., ATASEVER T., İNANIR S., GÖKÇORA N., GÜNEL N., et al.
6th Asia Oceania Congress of Nuclear Medicine and Biology, 30 September - 04 October 1996, (Summary Text) Sustainable Development

15. A phase II study of cisplatin (P) and DTIC for metastatic colorectal carcinoma resistant to 5- Fluorouracil (5-FU).

İÇLİ F., ÇAY ŞENLER F., DİNÇOL D., ARICAN A., KARAOĞUZ H., GÜNEL N., et al.
Proceedings of American Society of Clinical Oncology, 14 - 17 May 1994, (Summary Text)

16. MINE-BOP in refractory or relapsed Non - Hodgkin’s lymphomas (NHL)

DİNÇOL D., İÇLİ F., ARICAN A., GÜNEL N., KARAOĞUZ H., DEMİRKAZIK A., et al.
Proceedings of American Society of Clinical Oncology, 14 - 17 May 1994, (Summary Text)

17. Comparison of EAP and FAM combination chemotherapies in advanced gastric cancer

İÇLİ F., KARAOĞUZ H., DİNÇOL D., GÜNEL N., DEMİRKAZIK A., ÜNER A., et al.
Proceedings of American Society of Clinical Oncology, 16 - 18 May 1993, (Summary Text) Sustainable Development

18. A phase II study of Ifosfamide in unresectable diffuse malignant mesothelioma (MM)

İÇLİ F., KARAOĞUZ H., DİNÇOL D., GÜNEL N., DEMİRKAZIK A., ÜNER A., et al.
Proceedings of American Society of Clinical Oncology, 16 - 18 May 1993, (Summary Text)

19. The evaluation of infectious episodes and bacterial colonization in the cancer patients

WİLKE A., DİNÇOL D., DEMİRKAZIK A., GÜNEL N., KARAOĞUZ H., ÜNER A.
5 th International Congress for Infectious Diseases, 7 - 11 June 1992, (Summary Text) Sustainable Development
Metrics

Publication

45

Publication (WoS)

12

Publication (Scopus)

14

Citation (WoS)

102

H-Index (WoS)

6

Citation (Scopus)

101

H-Index (Scopus)

6

Citation (Scholar)

30

H-Index (Scholar)

1

Project

7

Thesis Advisory

5

Open Access

5
UN Sustainable Development Goals